The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Healthcare & Insurance

Disclosure of received notifications

Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 July 2020  Disclosure of received notifications  Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies, Fagron received notifications of Norges Bank. 

Monday, July 06, 2020

ObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids

  PRIMROSE 1 achieved statistically significant and clinically meaningful results across primary and key secondary endpoints at week 24  PRIMROSE 2 results demonstrate sustained efficacy and continued safety of linzagolix at week 52 Results confirm linzagolix as a potential best-in-class

Monday, July 06, 2020

Success of the capital increase with pre-emptive subscription rights: €7.3 million raised to finance the Prima System PRIMAvera pivotal study

Success of the capital increase with pre-emptive subscription rights: €7.3 million raised to finance the Prima System PRIMAvera pivotal study                      Paris, 6 July 2020 – 7.00 a.m. CET - Pixium Vision (Euronext Growth Paris - FR0011950641 - ALPIX) (“Pixium

Monday, July 06, 2020

Idorsia announces positive results in the second Phase 3 study of daridorexant

Results confirm and reinforce the efficacy and safety profile from the first pivotal studyCompany targets filing the New Drug Application (NDA) around the end of 2020Idorsia to host an investor webcast to discuss the second Phase 3 results today at 14:00hrs CEST Allschwil, Switzerland – July

Monday, July 06, 2020

Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MALVERN, Pa., July 03, 2020 (GLOBE NEWSWIRE) -- Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation Committee of Baudax Bio’s Board of Directors approved inducement grants of stock options to purchase

Friday, July 03, 2020

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 3, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Société Générale S.A. has informed us that, as of July 1, 2020, Société

Friday, July 03, 2020

Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies

COPENHAGEN, Denmark, July 3, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. The

Friday, July 03, 2020

Ageas and BlackRock: Transparency notification

Ageas and BlackRock: Transparency notification In accordance with the rules on financial transparency*, BlackRock has notified Ageas on 2 July 2020 that, on 1 July 2020, its interest has exceeded the legal threshold of 5% of the shares issued by Ageas. Its current shareholding stands at 5.09%.

Friday, July 03, 2020

ECMOHO Announces First Quarter 2020 Unaudited Financial Results

SHANGHAI, China, July 03, 2020 (GLOBE NEWSWIRE) -- ECMOHO Limited (Nasdaq: MOHO) (“ECMOHO” or the “Company”), a leading integrated solutions provider in the non-medical health and wellness market in China, today announced its unaudited financial results for the first quarter ended March

Friday, July 03, 2020

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

Orphazyme A/SCompany announcement                                                                                       No. 39/2020                                                                                 

Friday, July 03, 2020

Major Shareholder Announcement

Company Announcement Major shareholder announcement for Genmab A/S Copenhagen, Denmark; July 3, 2020 – Genmab A/S (Nasdaq: GMAB) announces under reference to Section 30 of the Danish Capital Markets Act that Société Générale S.A. has informed us that, as of June 29, 2020, Société

Friday, July 03, 2020

ObsEva SA to present at ESHRE Virtual 36th Annual Meeting, July 5-8, 2020

  Geneva, Switzerland and Boston, MA – July 3, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that they will present at ESHRE Virtual 36th Annual Meeting,

Friday, July 03, 2020

Aurora Spine Announces New Chief Financial Officer

CARLSBAD, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Aurora Spine Corporation ("Aurora Spine" or the "Company") (TSX VENTURE:ASG) announced the promotion of Chad Clouse to the position of Chief Financial Officer (CFO), effective July 2, 2020. Mr. Clouse graduated from Pennsylvania State

Friday, July 03, 2020

CORRECTION – Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK, July 02, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today, Thursday, July 2nd, by Protara Therapeutics, Inc. (Nasdaq: TARA), please note that in the first paragraph, the amount of shares of common stock should be 25,700, not 3,700. The corrected

Thursday, July 02, 2020

Avricore Health Announces Shares for Debt Transaction

VANCOUVER, British Columbia, July 02, 2020 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to announce that it has entered into shares for debt agreements, to satisfy an aggregate of $126,949 of the Company’s outstanding debts. The Company has

Thursday, July 02, 2020

Novartis resolves legacy litigation matters, finalizing settlement of speaker program litigation with Government in the US and positioning company

Company finalizes USD 678 million settlement relating to suit challenging speaker programs and other promotional events conducted from 2002 through 2011 in the US as well as USD 51.25 million related to the company’s support of certain independent charitable co-pay foundations from 2010 to 2014As

Thursday, July 02, 2020

Braingrid Limited Provides Update On COVID-19 and Announces Request for Extension to File Interim Financial Statements and Management's Discussion

TORONTO, July 02, 2020 (GLOBE NEWSWIRE) -- Braingrid Limited (CSE: BGRD) (“Braingrid”) wishes to provide an update on the COVID-19 pandemic as it affects Braingrid and the status of the filing of its interim financial statements and accompanying management's discussion and analysis, and

Thursday, July 02, 2020

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., July 02, 2020 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome, today announced grants of stock

Thursday, July 02, 2020

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients

Sanofi and Regeneron provide update on Kevzara® (sarilumab) Phase 3 U.S. trial in COVID-19 patients PARIS and TARRYTOWN, N.Y. - July 2, 2020 – Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Phase 3 trial of Kevzara® (sarilumab) 400 mg in COVID-19

Thursday, July 02, 2020

miRagen Regains Compliance With Nasdaq Listing Requirements

BOULDER, Colo., July 02, 2020 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that on July 1, 2020 it received written notice from the Nasdaq Listing

Thursday, July 02, 2020

loading

© 2020 Stock News Now